Novavax Submits Application to the U.S. FDA for Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted as a Booster in Adults Aged 18 and OlderPRNewsWire • 08/15/22
Novavax Nuvaxovid™ COVID-19 Vaccine Approved in South Korea for Use in Adolescents Aged 12 Through 17PRNewsWire • 08/12/22
Novavax to Participate in Fireside Chat at the SVB Securities Virtual Vaccine ForumPRNewsWire • 08/11/22
China closes Tibet's Potala Palace over COVID outbreak, and Novavax stock is slammed by weak earnings and halving of sales guidanceMarket Watch • 08/09/22
Novavax slumps after halving its sales forecast amid global supply glut and low vaccine demandProactive Investors • 08/09/22
Novavax, Inc.'s (NVAX) CEO Stan Erck on Q2 2022 Results - Earnings Call TranscriptSeeking Alpha • 08/09/22